Neonatal community-acquired pneumonia: pathogens and treatment

J Paediatr Child Health. 2010 Nov;46(11):668-72. doi: 10.1111/j.1440-1754.2010.01814.x. Epub 2010 Aug 25.

Abstract

Aim: To analyse the bacterial pathogens and drug sensitivities for neonatal community-acquired pneumonia.

Methods: Seven hundred sixty sputum samples from newborns with community-acquired pneumonia were cultured to determine microbial organisms present and their drug sensitivities.

Results: Of the 760 specimens, 425 grew pathogens for a 55.9% positive rate. Among the 425 positive cultures, 278 grew gram-negative organisms (65.4%), 142 grew gram-positive organisms (33.3%), while 5 grew fungus (1.3%). The most common gram-negative organisms were Escherichia coli, Klebsiella pneumoniae and Hemophilus influenzae, while the most common gram-positive organisms were Staphylococcus aureus, Staphylococcus epidermidis and Staphylococcus haemolyticus. To the gram-negative organisms, the most sensitive drugs were meropenem, imipenem and amikacin, while to the gram-positive ones were vancomycin, teicoplanin and quinupristin/dalfopristin.

Conclusions: The most common causative bacteria were gram-negative organisms, which were highly sensitive to Meropenem, Imipenem and Amikacin, yet often treatable with more focused antibiotic coverage, which depended on the bacterium identified.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • China
  • Community-Acquired Infections / drug therapy*
  • Community-Acquired Infections / microbiology*
  • Drug Resistance, Bacterial
  • Female
  • Gram-Negative Bacteria / drug effects
  • Gram-Negative Bacteria / isolation & purification
  • Gram-Positive Bacteria / drug effects
  • Gram-Positive Bacteria / isolation & purification
  • Humans
  • Imipenem / therapeutic use
  • Infant, Newborn
  • Male
  • Meropenem
  • Microbial Sensitivity Tests
  • Pneumonia, Bacterial / drug therapy*
  • Pneumonia, Bacterial / microbiology*
  • Retrospective Studies
  • Sputum / microbiology
  • Thienamycins / therapeutic use
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Thienamycins
  • Vancomycin
  • Imipenem
  • Meropenem